Correction: Was kommt nach CDK4/6-Inhibition? Perspektiven beim fortgeschrittenen Mammakarzinom
Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, Rupert Bartsch

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Breast Cancer Therapies · Breast Cancer Treatment Studies · HER2/EGFR in Cancer Research
Correction:
Wien Klin Wochenschr 2025
10.1007/s00508-025-02582-y
In diesem Artikel fehlte am Ende das Formular zur Teilnahme an der DFP-Fortbildung. Dieses wurde nun ergänzt.
Der Originalbeitrag wurde korrigiert.
